Patients must have a Lansky or Karnofsky performance status score of >= 50, corresponding to Eastern Cooperative Oncology Group (ECOG) categories 0, 1 or 2; use Karnofsky for patients > 16 years of age and Lansky for patients =< 16 years of age; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Karnofsky >= 50% for patients > 16 years of age and Lansky >= 60 for patients =< 16 years of age; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Karnofsky >= 50% for patients > 16 years of age and Lansky >= 50 for patients =< 16 years of age \r\n* Note: Neurologic deficits in patients with CNS tumors must have been relatively stable for at least 7 days prior to study enrollment; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Karnofsky >= 50% for patients > 16 years of age and Lansky >= 50 for patients =< 16 years of age \r\n* Note: Neurologic deficits in patients with CNS tumors must have been relatively stable for at least 7 days prior to study enrollment; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Karnofsky >= 50% for patients > 16 years of age and Lansky >= 50 for patients =< 16 years of age; Note: Neurologic deficits in patients with CNS tumors must have been relatively stable for at least 7 days prior to study enrollment; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Karnofsky >= 50% for patients > 16 years of age and Lansky >= 50 for patients =< 16 years of age; note: neurologic deficits in patients with CNS tumors must have been relatively stable for at least 7 days prior to study enrollment; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Adequate performance status: children < 10-Lansky score >= 30; children >= 10-Karnofsky >= 30 (except for posterior fossa syndrome)
Karnofsky >= 50% for patients > 16 years of age and Lansky >= 50 for patients =< 16 years of age; NOTE: neurologic deficits in patients with CNS tumors must have been relatively stable for at least 7 days prior to study enrollment; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
ECOG performance score 0-3
Lansky performance status score >= 70 for patients =< 16 years of age
Karnofsky performance status score >= 70 for patients > 16 years of age
Lansky performance status score >= 50 for patients =< 16 years of age; Karnofsky performance status score >= 50 for patients > 16 years of age
Patients must have a Lansky or Karnofsky performance status score of >= 50, corresponding to Eastern Cooperative Oncology Group (ECOG) categories 0, 1 or 2; use Karnofsky for patients > 16 years of age and Lansky for patients =< 16 years of age; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Karnofsky >= 50% for patients > 16 years of age and Lansky >= 50 for patients =< 16 years of age\r\n* Note: Neurologic deficits in patients with CNS tumors must have been relatively stable for at least 7 days prior to study enrollment; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Karnofsky >= 50% for patients > 16 years of age and Lansky >= 50 for patients =< 16 years of age; Note: neurologic deficits in patients with CNS tumors must have been stable for at least 7 days prior to study enrollment; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Karnofsky >= 50% for patients > 16 years of age and Lansky >= 50 for patients =< 16 years of age; Note: Neurologic deficits in patients with CNS tumors must have been stable for at least 7 days prior to study enrollment; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Karnofsky >= 50% for patients > 16 years of age and Lansky >= 50 for patients =< 16 years of age\r\n* Note: Neurologic deficits in patients with CNS tumors must have been relatively stable for at least 7 days prior to study enrollment; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Karnofsky >= 50% for patients > 16 years of age and Lansky >= 50 for patients =< 16 years of age; Note: neurologic deficits in patients with CNS tumors must have been relatively stable for at least 7 days prior to study enrollment; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Karnofsky >= 50% for patients > 16 years of age and Lansky >= 50 for patients =< 16 years of age; Note: neurologic deficits in patients with CNS tumors must have been stable for at least 7 days prior to study enrollment; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Patients must have a performance status corresponding to Eastern Cooperative Oncology Group (ECOG) scores of 0, 1, or 2; use Karnofsky for patients > 16 years of age and Lansky for patients =< 16 years of age; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Lansky or Karnofsky Score must be ? 50
Lansky performance status >= 50
Karnofsky scores < 60 or Lansky score < 50
Performance status\r\n* Phase I: Karnofsky performance scale (KPS for > 16 years of age) or Lansky performance score (LPS for =< 16 years of age) assessed within one week of enrollment must be >= 50\r\n* Surgical study: Karnofsky performance scale (KPS for > 16 years of age) or Lansky performance score (LPS for =< 16 years of age) assessed within one week of enrollment must be >= 60\r\n* Patients who are unable to walk because of neurologic deficits, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Patients with an Eastern Cooperative Oncology Group (ECOG) score of =< 2 or Karnofsky score of >= 50
Karnofsky >= 50% for patients > 16 years of age and Lansky >= 50% for patients =< 16 years of age; Note: Neurologic deficits in patients with metastatic CNS tumors must have been relatively stable for a minimum of 1 week prior to study enrollment; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Patients must have a Lansky (?16 years) or Karnofsky (> 16 years) score of at least 50
Karnofsky/Lansky performance score ? 60
Have a Lansky score ? 40 for subjects up to 16 years of age or a Karnofsky score ? 40 for subjects 16 years of age to < 18 years
Lansky (for research participants =< 16 years) or Karnofsky (for research participants > 16 years) performance score >= 40 at the time of study enrollment
Karnofsky >= 50% for subjects > 16 years of age and Lansky >= 50 for subjects =< 16 years of age; Note: subjects who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Nottingham score of 3 (specially nuclear and mitotic score>2)
Patients must be ambulatory and have an ECOG Performance Score of 0 or 1;
TREATMENT: Patients with a Karnofsky/Lansky score of >= 50%
IPSS score <= 16.
Lansky >= 50 for patients =< 10 years of age or as per institutional guidelines; Note: Patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Karnofsky score of > 60%
Patients with a Karnofsky score of >= 50
Karnofsky score > 70 %.
Patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Subjects must have a Karnofsky score (KPS) of ? 60 at Screening.
Participants =< 12-15 years Lansky 100-70%
Performance status Lansky (age < 16) or Karnofsky score (age >= 16) >= 80%
Performance status: Lansky >= 50 for patients who are =< 16 years old and Karnofsky >= 50% for patients who are > 16 years old
Karnofsky performance score >= 70
Patients with an Eastern Cooperative Oncology Group (ECOG) score of ? 2 or Karnofsky score of ? 50
INCLUSION - TREATMENT: Karnofsky or Lansky score of > 60%
Patients must have a Lansky or Karnofsky performance status score of >= 50, corresponding to Eastern Cooperative Oncology Group (ECOG) categories 0, 1 or 2. Use Karnofsky for subjects >= 16 years of age and Lansky for subjects <= 16 years of age.
Karnofsky >= 50% for patients > 16 years of age and Lansky >= 50 for patients =< 16 years of age; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Karnofsky performance status >= 50% for patients > 16 years of age and Lansky >= 50 for patients =<16 years of age; Note: neurologic deficits in patients with CNS tumors must have been relatively stable for at least 7 days prior to study enrollment; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Karnofsky >= 50% for patients > 16 years of age and Lansky >= 50 for patients =< 16 years of age; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Patient must have a Karnofsky (if >= 16 years of age) or Lansky performance score (if =< 15 years of age) of >= 50 by the time of registration; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Performance status: Karnofsky score greater than or equal to 70%. Additional Patient Inclusion Criteria for Conditioning:
Moderate cGvHD: At least one organ (not lung) with a score of 2, 3 or more organs involved with a score of 1 in each organ, or lung score of 1
Severe cGvHD: at least 1 organ with a score of 3, or lung score of 2 or 3
Karnofsky performance scale ([KPS] for > 16 yrs of age) or Lansky performance score ([LPS] for =< 16 years of age) >= 50
Karnofsky Performance Score < 70%
Karnofsky performance scale (KPS for >= 16 years of age) or Lansky performance score (LPS for =< 15 years of age) >= 60 assessed within 14 days prior to registration
Gleason score, obtained at biopsy, =< 6, 3 + 4 = 7, or 4 + 3 = 7
Karnofsky >= 50 for patients >= 16 years of age, and Lansky >= 50 for patients < 16 years of age; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
ECOG Score of 0-2
INCLUSION - INFUSION: Patients with a Karnofsky/Lansky score of ? 60
PROCUREMENT INCLUSION: Karnofsky or Lansky score of > 60%
TREATMENT INCLUSION: Karnofsky or Lansky score of > 60%
Karnofsky Performance Score of ? 70% at the time of entry
Eastern Cooperative Oncology Group (ECOG) performance score 0-2, inclusively or Lansky score ? 60, as age appropriate
Participants with lansky-Karnofsky score of greater than or equal to (>=) 50
Patient may not have a Karnofsky performance score < 50% or Lansky performance score < 50%
Lansky score <50%
Karnofsky/Lansky score of ? 50
Performance status: Karnofsky/Lansky score > 50%.
Karnofsky/Lansky score of ? 50
Karnofsky performance scale (KPS for > 16 years of age) or Lansky performance score (LPS for =< 16 years of age) assessed within two weeks of enrollment must be >= 70; patients who are unable to walk because of neurologic deficits, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
INCLUSION CRITERIA FOR STRATUM C: Karnofsky performance scale (KPS for > 16 years of age) or Lansky performance score (LPS for =< 16 years of age) assessed within two weeks of enrollment must be >= 60; patients who are unable to walk because of neurologic deficits, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Patients >= 16 years of age: Karnofsky >= 50%; patients =< 16 years of age: Lansky scale >= 50%; subjects who are unable to walk because of paralysis, but who are upright in a wheelchair will be considered ambulatory for the purpose of calculating the performance score
ELIGIBILITY CRITERIA AT TIME OF TREATMENT: Patients with a Karnofsky/Lansky score of ? 50
Karnofsky performance scale (KPS for > 16 years of age) or Lansky performance score (LPS for =< 16 years of age) assessed within two weeks of enrollment must be >= 60
Patients with a Karnofsky/Lansky score of ? 50
Karnofsky (> 16 years of age) or Lansky (=< 16 years of age) performance status (PS) 60–100%; Note: patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Karnofsky/Lansky score ? 50%
Patients must have a Lansky performance status score of >= 50 or a Karnofsky score of >= 50 for patients >= 16 years of age; Note: Patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Patients must have a Lansky or Karnofsky performance status score of >= 50; use Karnofsky for patients > 16 years of age and Lansky for patients =< 16 years of age
INCLUSION - PROCUREMENT: Karnofsky/Lansky score of ? 50
INCLUSION - TREATMENT: Karnofsky/Lansky score of ? 50
Performance level corresponding to Eastern Cooperative Oncology Group (ECOG) score of 0, 1, or 2; the Lansky performance score should be used for participants < 16 years
Patient must have a Karnofsky performance status or Lansky* play status >= 50\r\n* For purpose of determining performance scores, wheelchair-bound patients will be considered ambulatory
Performance status score: Karnofsky (for adults) >= 70% or Eastern Cooperative Oncology Group (ECOG) 0-1 or Lansky (for children) >= 50%
AUTOLOGOUS APHERESIS: Karnofsky or Lansky (age-dependent) performance score >= 50
MANUFACTURING SJCAR19: Karnofsky or Lansky (age-dependent) performance score >= 50
TREATMENT WITH SJCAR19: Karnofsky or Lansky (age-dependent) performance score >= 50
Karnofsky >= 50 for patients > 16 years of age and Lansky >= 50 for patients =< 16 years of age. Patients who are unable to walk because of paralysis, but who are able to mobilize using a wheelchair, will be considered ambulatory for the purpose of assessing the performance score.
Karnofsky or Lansky performance score is ? 50% (corresponding to Eastern Cooperative Oncology Group [ECOG] score of ? 2); the Lansky performance score should be used for participants < 16 years and the Karnofsky performance score for participants ? 16 years; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Clinical performance status: Patients > 16 years of age: Karnofsky ? 50%; patients < 16 years of age: Lansky scale ? 50%; subjects who are unable to walk because of paralysis, but who are upright in a wheelchair will be considered ambulatory for the purpose of calculating the performance score
STRATUM A: Participants must have a Lansky (=< 16 years) or Karnofsky (> 16 years) score of at least 50 at the time of study enrollment; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
STRATUM B: Participants must have a Lansky (=< 16 years) or Karnofsky (> 16 years) score of at least 50 at the time of study enrollment; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
STRATUM C: Participants must have a Lansky (=< 16 years) or Karnofsky (> 16 years) score of at least 50 at the time of study enrollment; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Performance score (PS) of 0-2 by Zubrod score
Performance status: Lansky Play-Performance Scale ?50 for children up to and including 16 years of age OR Karnofsky score ?50 for participants >16 years of age
Karnofsky >= 50% for patients > 16 years of age and Lansky >= 50 for patients =< 16 years of age; Note: neurologic deficits in patients with CNS tumors must have been relatively stable for at least 7 days prior to study enrollment; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Performance score > 70% (use Lansky score for age < 16 and Karnofsky score for age >= 16)
Karnofsky >= 50% for patients > 16 years of age and Lansky >= 50 for patients =< 16 years of age; Note: Neurologic deficits in patients with CNS tumors must have been relatively stable for at least 7 days prior to study enrollment; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Performance score using the Karnofsky performance scale (patients > 12 years old) or Lansky Play - performance scale (patients =< 12 years old) must be >= 60 assessed within two weeks prior to enrollment
Karnofsky >= 50% for patients > 16 years old, and Lansky >= 50 for patients 1-16 years old
Karnofsky performance scale (KPS for > 16 years [yrs.] of age) or Lansky performance score (LPS for =< 16 years of age) >= 60 assessed within two weeks prior to registration
Karnofsky > 50% for patients > 16 years of age and Lansky > 50% for patients < 16 years of age; neurologic deficits in patients with central nervous system (CNS) tumors must have been relatively stable for a minimum of 7 days; patients who are unable to walk because of paralysis, but who are able to sit in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Subjects must have a Lansky performance status score of >= 50 or a Karnofsky score of >= 50 for subjects >= 16 years of age; Note: Subjects who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Patients must have a Karnofsky >= 50% for subjects > 16 years of age and Lansky score >= 50 for subjects =< 16 years of age \r\n* Note: Subjects who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Karnofsky performance score > 60
Karnofsky performance status (KPS) of > 60% (KPS for > 10 years of age) or Lansky performance Score (LPS) of >= 60 (LPS for =< 10 years of age) assessed within 2 weeks prior to registration; patients who are unable to walk because of paralysis but who are up in a wheel chair will be considered ambulatory for the purposes of the performance score
Lansky or Karnofsky performance score >= 60
Karnofsky performance score (KPS) score >= 70
Performance status as determined by Karnofsky >= 60 or Lansky play scale >= 60% at the time of study drug administration
ECOG score 2 or less
Subject has Karnofsky (age ? 16 years) or Lansky (age < 16 years) performance status score ? 50 at screening
Have Karnofsky score ?40 at enrollment (not applicable for subjects with benign bone tumors)
Karnofsky scores < 60 or Lansky score < 50
Participant's performance score must be ?50% Karnofsky (for participants >16 years of age) or Lansky (for participants less than or equal to (?)16 years of age).Participants who are unable to walk because of paralysis and/or previous surgeries, but who are in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score.
Subjects must have a Lansky performance status score of >= 50 or a Karnofsky score of >= 50 for subjects >= 16 years of age; Note: subjects who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Patients must have a Lansky performance status score of >= 50, or a Karnofsky score of >= 50 for patients >= 16 years of age; Note: Patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Karnofsky performance score of greater than or equal to 70
Karnofsky performance score >= 70
Karnofsky performance score (KPS) >= 70%
Karnofsky performance status >= 80% for patients >= 16 years of age or Lansky play score >= 80 for patients < 16 years of age\r\n* Note: if poor performance status is due to lymphoma - Karnofsky performance status (KPS) >= 60% or Lansky performance score (LPS) >= 60 is acceptable
ECOG score 2
Performance score of at least 80% by Karnofsky or performance score (PS) < 3 (Eastern Cooperative Oncology Group [ECOG]) (age >= 12 years), or Lansky play-performance scale of at least 60% or greater (age < 12 years).
Karnofsky >= 50 for patients > 16 years of age and Lansky >= 50 for patients =< 16 years of age; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
The patient must have a Lansky or Karnofsky performance score (KPS) of >= 70% at the time of entry
Patients must have a Karnofsky performance score (KPS) > 60.
Have a Karnofsky performance score (KPS) >= 60
ECOG performance score of 0 or 1 .
Subjects must have Karnofsky >= 50%; Note: subjects who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Karnofsky performance score must be >= 60
Performance status: Lansky or Karnofsky score ? 60% and minimum life expectancy of at least 4 weeks
CELL PROCUREMENT: Karnofsky score > 60% if >= 16 years old or Lansky performance score of greater than 60% if < 16 years old
LYMPHODEPLETION: Karnofsky score > 60% if >= 16 years old or Lansky performance score of greater than 60% if < 16 years old
Karnofsky score (adults) < 60% or Lansky score < 50% (pediatrics)
Adequate performance status is defined as Karnofsky score >= 70% (> 16 years of age) or Lansky score >= 70 (pediatrics)
Karnofsky performance score (KPS) >= 70%
Osteoporosis, defined as T-score less than -2.5
Performance level: \r\n* Lansky score >= 60% (patients < 16 years of age)\r\n* Karnofsky score >= 60% (patients >= 16 years of age)
Karnofsky >= 50% for patients > 16 years of age and Lansky >= 50 for patients =< 16 years of age\r\n* Note: Neurologic deficits in patients must have been relatively stable for at least 7 days prior to study enrollment; patients who are unable to walk because of paralysis, but who are in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Performance score of >= 70 by Karnofsky/Lansky or performance score (PS) 0 to 1 (Eastern Cooperative Oncology Group [ECOG] =< 1)
Karnofsky or Lansky (age-dependent) performance score >= 50
PART 2 GROUP 1 INCLUSION CRITERIA: Performance status:\r\n* Karnofsky score >= 50 for subjects >16 years of age\r\n* Lansky score >= 50 for subjects =< 16 years of age\r\n* Note: subjects who are unable to walk because of paralysis, but who are mobile in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
PART 2 GROUP 2A INCLUSION CRITERIA: Performance status:\r\n* Karnofsky score >= 50 for subjects >16 years of age\r\n* Lansky score >= 50 for subjects =< 16 years of age\r\n* Note: subjects who are unable to walk because of paralysis, but who are mobile in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
PART 2 GROUP 3 INCLUSION CRITERIA: Performance status:\r\n* Karnofsky score >= 50 for subjects >16 years of age\r\n* Lansky score >= 50 for subjects =< 16 years of age\r\n* Note: subjects who are unable to walk because of paralysis, but who are mobile in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Karnofsky score of >= 50 for patients > 16 years of age; or
Lansky score of >= 50 for patients =< 16 years of age
Karnofsky performance status score (age >= 16 years) or Lansky play score (age < 16 years) =< 40%
Patients must have a performance status corresponding to Karnofsky or Lansky greater than or equal to 50%; use Karnofsky for patients > 16 years of age and Lansky for patients =< 16 years of age; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Performance score of at least 60% by Karnofsky
Karnofsky score >= 70% (>= 16 years) or Lansky score >= 50 (< 16 years)
Adequate performance status is defined as Karnofsky score >= 70% (>= 16 years of age) or Lansky score >= 50 (pediatrics)
Lansky/Karnofsky performance status score of 50-100
PRIOR TO CELL PROCUREMENT: Karnofsky or Lansky score of > 60% (Karnofsky for ? 16 years old and Lansky for < 16 years old)
PRIOR TO LYMPHODEPLETION: Karnofsky or Lansky score of > 60% (Karnofsky for pediatric patients ? 16 years old and Lansky for < 16 years old)
PRIOR TO INFUSION OF ATLCAR.CD30 CELLS: Karnofsky or Lansky score of > 60% (Karnofsky for ? 16 years old and Lansky for < 16 years old)
Patients must have a performance status corresponding to Karnofsky or Lansky greater than or equal to 50%; use Karnofsky for patients > 16 years of age and Lansky for patients =< 16 years of age; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Karnofsky performance scale (KPS) score >= 70
Age 0 to 70 years of age with Karnofsky score >= 70% (>= 16 years) or Lansky score >= 50 (< 16 years)
Karnofsky Performance Score (KPS) >= 50% for patients >= 10 years of age; Lansky score of >= 50 for children < 10 years of age
Patient has an ECOG Performance Status score of 0 or 1 (solid tumors) or KPS score ? 70 (rHGG).
IPSS score =< 15
IPSS score > 15
Lansky/Karnofsky performance scale > 60%
Lansky or Karnofsky ?50
Karnofsky >= 50% for patients > 16 years of age and Lansky >= 50 for patients =< 16 years of age; Note: neurologic deficits in patients with CNS tumors must have been stable for at least 7 days prior to study enrollment; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Performance status defined by Karnofsky or Lansky >= 60 (except for patients with posterior fossa syndrome); use Karnofsky for patients >= 16 years and Lansky for patients < 16 years; note: patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered to be ambulatory for the purpose of assessing the performance score
Performance status:\r\n* Lansky >= 50 for individuals 18 months- =< 16 years old; Karnofsky > 50% for individuals 17-21 years old
Eastern Cooperative Oncology Group (ECOG) score of =< 2 or Karnofsky/Lansky score >= 50%
Patients must have Karnofsky performance score >= 70
AT THE TIME OF PROCUREMENT: Karnofsky score of ? 60
AT THE TIME OF INFUSION: Karnofsky score ? 60
Karnofsky >= 60% for subjects > 16 years of age and Lansky >= 50 for subjects =< 16 years of age; note: subjects who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
PROCUREMENT: Karnofsky score ? 50%
TREATMENT: Karnofsky score ? 50%
Patients must have a Lansky Play Scale of 60% (< 16 years [yrs] old), Karnofsky score 60% (> 16 yrs old), or Eastern Cooperative Oncology Group (ECOG) score of < or equal to 2 and a life expectancy of 2 months
Karnofsky performance status of >= 60% or, if less than 16 years of age Lansky play score of >= 60
Karnofsky performance score >= 60
Gleason score 6-10
Karnofsky performance score >= 70%
Performance level: Karnofsky > or equal to 50% for patients > 10 years of age or Lansky > or equal to 50 for patients < 10 years of age; Note: patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Patient must have a Lansky performance status score of >= 50; Note: patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
TREATMENT: Patients with a Karnofsky score of ? 50
Lansky score of 50 or greater if =<16 years of age or a Karnofsky score of 50 or greater if > 16 years of age (NOTE: patients who are unable to walk because of paralysis, but who are in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score)
Karnofsky/Lansky score >= 60%
Patients must have a performance status of 0, 1 or 2 (Appendix I). Patients who are unable to walk because of paralysis or tumor pain, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Karnofsky score of >= 70%
Lansky score <50%
Karnofsky performance score < 70
Karnofsky score (KS) >= 50
Performance score of at least 70% by Karnofsky or 0 to 1 by Eastern Cooperative Oncology Group (ECOG) (age >= 12 years), or Lansky Play-performance scale of at least 70% or greater (age < 12 years)
Patient must have a Karnofsky performance score of >= 70
Karnofsky or Lansky score of > 60%
Karnofsky score >= 70
Karnofsky or Lansky (age-dependent) performance score >= 50
Patients < age 60 years must have a Karnofsky performance status (KPS) of >= 80% and a hematopoietic cell transplant comorbidity index (HCT-CI) score of 5 or less
Adequate Karnofsky Performance score or Lansky Play-Performance scale
Patients with a Karnofsky/Lansky score of >= 50
The patient must be in adequate general condition for study, with Lansky or Karnofsky performance score of >= 50 at study entry; Lansky performance scale will be used for patients =< 16 years of age
Karnofsky performance status (KPS) or Lansky score >= 20
ASA score 1-3.
Karnofsky performance status (KPS) or Lansky score > 50
Karnofsky performance scale (KPS for > 16 years of age) or Lansky performance score (LPS for =< 16 years of age) assessed within two weeks of enrollment must be >= 60; patients who are unable to walk because of neurologic deficits, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Karnofsky performance scale (KPS for > 16 years of age) or Lansky performance score (LPS for =< 16 years of age) >= 50 assessed within 2 weeks prior to registration
For subjects < 17 years of age, Modified Lansky Play-Performance Score of >= 70%; for subjects 17 and older, Karnofsky score of >= 70%
Lansky/Karnofsky scores >= 60
Karnofsky or Lansky score of > 60%
Lansky or Karnofsky score < 50%
Gleason score 8 or higher
Karnofsky/Lansky score >= 60%
Karnofsky score < 50% for adult patients
Lansky play-performance score < 40 for pediatric patients
Lansky/Karnofsky >= 50 (Lansky for subjects 7 - 15 years; Karnofsky for subjects 16 - 30 years); subjects who are unable to walk because of paralysis, but who are up in a wheelchair will be considered ambulatory for the purpose of assessing the performance score
Karnofsky/Lansky score of >= 50
Karnofsky/Lansky score of >= 50
Gleason score of 3+4 or lower
Gleason (4+3) or higher score
Patients =< 50 must have performance status score: Karnofsky (for adults) >= 70 or Eastern Cooperative Oncology Group (ECOG) 0-1; Lansky (for children) score >= 50
Patients > 50 must have Karnofsky performance score >= 70 or ECOG 0-1 and comorbidity index < 5
Karnofsky score > 70 %
Performance status score: Karnofsky (for adults) >= 60 or ECOG 0-2; Lansky (for children) score >= 50
Adequate performance status; Lansky score >= 60% for children < 16 years of age, or Karnofsky score >= 60% for those > 16 years of age
Lansky play score >= 50
Recipients must have a Karnofsky score (adults) >= 80 % or Lansky score >= 50% (pediatrics)
Adequate performance status is defined as Karnofsky score >= 60% (> 16 years of age) or Lansky score >= 50 (pediatrics)
Performance level: Performance score ?50%. Karnofsky (for participants >16 years of age) or Lansky (for participants ?16 years of age)
Karnofsky >= 80%, Lansky play score >= 70
Evidence of cirrhosis, documented by one of the following: Liver biopsy histologic diagnosis: Metavir Score greater than 3 (includes 3 - 4 or ¾) or Ishak score greater than 4 In the absence of liver biopsy: a FibroScan score greater than or equal to 12.5 kPa or Fibrotest score of >0.75 AND an APRI score greater than 1.5
Karnofsky performance score (KPS) ? 70%
Karnofsky performance score 70
Karnofsky performance score 70
KPS Score < 60 (See \Definitions\ below)
ASA score 1-2.
Patients must have a performance status of >= 50 by Lansky or Karnofsky, corresponding to Eastern Cooperative Oncology Group (ECOG) scores of 0, 1, or 2. Use Karnofsky for patients > 16 years of age and Lansky for patients =< 16 years of age. Patients who are unable to walk because of paralysis, but are up in a wheelchair will be considered ambulatory for the purposes of assessing the performance score
Patients must have a Lansky (?16 years) or Karnofsky (> 16 years) score of at least 50
Patients should have a performance status (Karnofsky score) of > 80 out of 100, i.e. can carry on normal activity with effort while showing some signs or symptoms of disease
Lansky (=< 10 years) or Karnofsky (> 10 years) score of at least 50
Karnofsky performance score (KPS) >= 70
Karnofsky ? 60 for subjects > 16 years of age and Lansky ? 50 for subjects ? 16 years of age \r\n* Note: subjects who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Karnofsky performance score 70% or higher.
Performance Status: Karnofsky ? 70%, Lansky play score ? 70
Karnofsky Performance Scale score >= 60%
Karnofsky >= 50% for patients > 16 years of age and Lansky >= 50 for patients =< 16 years of age; Note: Neurologic deficits in patients with CNS tumors must have been stable for at least 7 days prior to study enrollment; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Karnofsky performance scale (KPS for > 16 years of age) or Lansky performance score (LPS for =< 16 years of age) assessed within two weeks of enrollment must be >= 60; patients who are unable to walk because of neurologic deficits, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Karnofsky >= 50 for patients >= 16 years of age, and Lansky >= 50 for patients < 16 years of age; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score; patients with pre-existing neurological deficits need to be stable prior to surgery or lumbar puncture (LP) as determined by the investigator
Karnofsky (those 16 years old or older) or Lansky (those younger than 16 years) performance score of at least 50
Subject's Karnofsky performance status (KPS) must be >= 50% (Eastern Cooperative Oncology Group [ECOG] performance score < 3); the Lansky scale will be used for subjects less than 16 years of age and must be >= 50%
Patients must have a performance status corresponding to Eastern Cooperative Oncology Group (ECOG) scores of 0, 1, or 2; use Karnofsky for patients > 16 years of age and Lansky for patients =< 16 years of age; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Karnofsky performance score >= 70
Performance status: Karnofsky >= 50% for patients > 16 years of age and Lansky >= 50% for patients =< 16 years of age; subjects who are wheelchair bound because of paralysis will be considered “ambulatory” when they are up in their wheelchair; subjects have to be able to travel to the NIH for evaluations
Patients must have a Lansky or Karnofsky performance status score of >= 70; Karnofsky system will be used for patients > 16 years of age and Lansky system for patients < 16 years of age
Karnofsky score >= 80% (adults), Lansky score >= 50% (pediatrics)
Patients must meet one of the following performance scores:\r\n* Eastern Cooperative Oncology Group (ECOG) performance status scores of 0, 1, or 2; \r\n* Karnofsky score of >= 60 for patients > 16 years of age; or\r\n* Lansky score of >= 60 for patients =< 16 years of age
Patients must have a performance status corresponding to an Eastern Cooperative Oncology Group (ECOG) scores of 0, 1 or 2; use Karnofsky for patients > 16 years of age and Lansky for patients =< 16 years of age; Note: patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Patients must have a Karnofsky performance score of 50% or greater
Karnofsky performance score >= 70%
Sensitivity score =< 3
Lansky (=< 16 years) or Karnofsky (> 16 years) score of at least 50
Adequate functional status (Karnofsky Performance Score ?60)
Patients with a Karnofsky performance score < 70% or Lansky score < 70%
Patients must have a Lansky or Karnofsky performance status score of >= 50, corresponding to Eastern Cooperative Oncology Group (ECOG) categories 0, 1 or 2; use Karnofsky for patients > 16 years of age and Lansky for patients =< 16 years of age; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Karnofsky >= 50% for patients > 16 years of age and Lansky >= 50 for patients =< 16 years of age; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Any Gleason score > 3 + 4 or Gleason score 3 + 4 with the secondary pattern exceeding 50%
Karnofsky >= 50% for patients > 16 years of age and Lansky >= 50 for patients =< 16 years of age; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Karnofsky >= 50% for patients > 16 years of age and Lansky >= 50 for patients =< 16 years of age; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Karnofsky >= 50% for patients > 16 years of age and Lansky >= 50 for patients =< 16 years of age; Note: neurologic deficits in patients with CNS tumors must have been relatively stable for at least 7 days prior to study enrollment; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
With Karnofsky index or Lansky play-performance scale > 70% on pre-transplant evaluation
DONOR: Donors in good general health, with a Karnofsky or Lansky play performance score > 90%
Karnofsky/Lansky score of 60% or greater
Patient with a Karnofsky performance score < 50% or Lansky score < 50%
Karnofsky >= 60% for patients > 16 years of age and Lansky >= 50 for patients =< 16 years of age; Note: patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Clinical performance status: patients > 10 years of age: Karnofsky >= 50%; patients =< 10 years of age: Lansky scale >= 50%; subjects who are unable to walk because of paralysis, but who are upright in a wheelchair will be considered ambulatory for the purpose of calculating the performance score
Patients should have a Karnofsky/Lansky score of greater than or equal to 60; patients who require special assistance due to tumor-related paralysis, but who are out of bed during the day will be considered ambulatory for the purpose of calculating the performance score; patients must be able to communicate any symptoms
Patients must have a Lansky or Karnofsky performance status score of >= 50%, corresponding to Eastern Cooperative Oncology Group (ECOG) categories of 0, 1, or 2 (use Karnofsky for patients > 16 years of age and Lansky for patients =< 16 years of age)
Karnofsky performance score < 70%
Performance level: Karnofsky >= 50 for patients > 16 years of age and Lansky >= 50 for patients =< 16 years of age); Note: patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Karnofsky/Lansky score of >= 50
Karnofsky/Lansky score of >= 50
Karnofsky/Lansky score of > 60%
Subject has a Karnofsky score of ? 50% (subjects ? 16 years of age) or a Lansky score ? 50% (subjects < 16 years of age).
Gleason score 6 (3+3) and
Subjects must have an ECOG Performance Score of 0-1.
Karnofsky performance score greater than or equal to 70%
Lansky/Karnofsky score > 50
Karnofsky Performance Score (KPS) ? 70%
Gleason score ? 3 + 4
Lansky score >50% for participants <16 years old.
Gleason 8 or higher score
ECOG Score ?2
Karnofsky performance score < 70% or Lansky-Play Performance score < 70 for pediatric patients
Karnofsky Performance Scale (KPS) score ?60
Adequate performance, i.e.\Karnofsky Performance Score\ of at least 70%;
Karnofsky performance status (KPS) or Lansky score >= 60
EXCLUSION FOR COLLECTION OF T CELLS/PBMCS: Karnofsky/Lansky performance status < 60
Karnofsky or Lansky ? 50
Adequate Karnofsky Performance score or Lansky Play-Performance scale
Karnofsky score < 60 or Lansky score < 50
Performance Status • Karnofsky > 50 % for patients >16 years of age or Lansky > 50 for patients < 16 years of age. Patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score.
Gleason score 7;
Internation Prostate Symptom Score score must be ? 15 (alpha blockers allowed);
Gleason score > 7
Have good performance score (0-1).
Performance status as determined by Karnofsky >= 60% or Lansky play scale >= 60% at the time of study drug administration
Karnofsky/Lansky score >= 50%
Karnofsky/Lansky score >= 50%
Karnofsky performance score 70% or higher
Karnofsky or Lansky score of > 60%
Patients must have Karnofsky performance score (for patients > 16 years of age) or Lansky performance score (for patients =< 16 years of age) >= 50% assessed within two weeks of study enrollment; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Subject has an Eastern Cooperative Oncology Group (ECOG) score of 0 1 or Karnofsky Performance Status Score ? 70.
Performance status: Karnofsky or Lansky score ? 60% (Appendix A)
Performance status: Lansky >= 50 for patients who are =< 16 years old and Karnofsky >= 50% for patients who are > 16 years old
Have a Karnofsky score ? 70
Subject has a TBS with an SBSS score of 1, 2, or 3.
All patients must have a Karnofsky performance score > 60%
Lansky score < 60%
Karnofsky or Lansky performance status (PS): performance status of >= 50 assessed within two weeks prior to registration; neurological deficits in patients must have been relatively stable for a minimum of 1 week prior to study enrollment; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Karnofsky performance scale (KPS for > 16 years of age) or Lansky performance score (LPS for =< 16 years of age) assessed within 14 days of enrollment must be >= 50
Patients must have an ECOG performance score between 0 and 1.
Patients must have an ECOG Performance Score of 0 or 1.
Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%); Note: patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purposes of assessing the performance score
Karnofsky score >= 50 for patients >= 16 years of age and Lansky score >= 50 for patients =< 15 years of age; patients who are unable to walk because of paralysis but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Karnofsky >= 50%; Note: subjects who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
AT THE TIME OF INFUSION: Karnofsky or Lansky score of ? 50%
Karnofsky performance score ?70.
Karnofsky Performance Score (KPS) of ? 70%
Karnofsky performance score of 70 or higher
Karnofsky >= 50% for patients > 16 years of age and Lansky >= 50% for patients =< 16 years of age; neurologic deficits in patients with central nervous system (CNS) tumors must have been relatively stable for a minimum of 7 days; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Lansky (for participants 10 years of age or younger) or Karnofsky (for participants older than 10 years) performance score greater than 50
ECOG performance score ? 1
Patients must have Karnofsky performance score >= 60
Patient must have a score on the Karnofsky performance scale of >= 80%
Karnofsky performance scale (KPS for >= 16 years [yrs] of age) or Lansky performance score (LPS for < 16 years of age) >= 60 assessed within two weeks prior to registration
The patient has a Lansky/ Karnofsky performance status score of ? 70%
Karnofsky Performance Scale (KPS) score greater than or equal to 60.
Performance status: Karnofsky or Lansky scores ? 50 for subjects > 16 years old or ? 16 years old, respectively.
Karnofsky performance score (KPS) >= 70%
Karnofsky performance score ?50 for participants>16 year of age and Lansky play score ?50 for participants ?16 years of age. Neurologic deficits in participants with CNS tumors must have been relatively stable for at least 7 days prior to study enrollment. Participants who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Patients must have a Karnofsky performance score (KPS) of >= 60
ECOG score of 0 or 1
Karnofsky >= 50% for patients > 16 years of age and Lansky >= 50 for patients =< 16 years of age; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
The patient must have a Karnofsky performance score of 40 or greater
Karnofsky performance score (KPS) >= 60%
Must have a Lansky or Karnofsky performance status of >= 50; use Karnofsky for patients > 16 years of age and Lansky for patients =< 16 years of age
Patients >= 45 years: comorbidity score of 5 or higher
Karnofsky performance score >= 60%
Karnofsky score >= 70 or Lansky score >= 70
Karnofsky Performance Score ?70%
Performance score >= 50 (Lansky for research participants =< 16 years and Karnofsky for those > 16 years)
Subjects must have a performance score of Karnofsky >= 70% at the time of entry into the study
Karnofsky or Lansky performance score of greater than or equal to 50
Karnofsky Performance Score (KPS)>=60.
Patients must have a Lansky or Karnofsky performance status score of >= 60%; use Karnofsky for patients > 16 years of age and Lansky for patients =< 16 years of age
Performance status: Lansky >= 50 for individuals 18 months to < 10 years old; Karnofsky > 50% for individuals 10-21 years old
Karnofsky performance scale >= 30 (>= 50 for patients ages 60-70 years)
The patient must have a Karnofsky performance score (KPS) of >= 70% at the time of entry
Performance score of >= 60 by Karnofsky or performance score (PS) 0 to 2 (Eastern Cooperative Oncology Group [ECOG]) (age > 12 years), or Lansky play-performance scale >= 60 or greater (age < 12 years)
Lansky/Karnofsky performance status score of 40-100
Karnofsky/Lansky performance score < 70%.
Lansky play score >= 60 (< 16 years) or Karnofsky (16 years or older) performance score of >= 60%
Karnofsky performance score (KPS) < 70%
Karnofsky performance score >= 60
Karnofsky score > 50%
Patient must have proven positive tumor sample for NY-ESO-1 as determined by an H score for immunohistochemistry staining. Positive expression is defined as an H score ? 100 where the H score = [2 x (% cells 2+) + 3 x (% cells 3+)]. NOTE: The percentages of negative or weakly stained nuclei (i.e. 1+) are not to be included in the calculation of the H score.
ECOG Performance Score of 0 or 1
For men =< 70 years, biopsy Gleason score =< 6; for men > 70 years, biopsy Gleason score =< (3 + 4) = 7
Karnofsky scores < 60 or Lansky Score < 50
Karnofsky performance scale >= 12 years old (y/o) or Lansky performance score for patients < 12 y/o must be >= 50 assessed within two weeks prior to enrollment
Performance Status: Eastern Cooperative Oncology Group (ECOG) score ? 3 (age ?16) or Lansky Performance Score (LPS) ?40% (age<16). If enrolled with primary CNS tumor to be assessed by RANO, Karnofsky Performance Status (KPS) (age ?16) or LPS (age<16) ? 50%
Karnofsky performance score (KPS) >= 70%
Patients must have a Karnofsky performance scores (KPS) of at least 70 at the first postoperative visit; patients under 18 years of age must have a Lansky performance score of at least 70
Lansky performance score >= 50% for patients =< 16 years of age, or Zubrod performance status score of 0-2 for patients > 16 years of age
Patients with a Karnofsky/Lansky score >= 50
Karnofsky performance score < 60 Lansky performance score < 60
Lansky or Karnofsky scale >50
Performance Score: Karnofsky ?60% if >10y/o, Lansky ?60 if ?10y/o
Karnofsky performance score (KPS) or Lansky score >= 40
Adequate performance status as defined by Lansky Score >= 30 (except for Posterior Fossa Syndrome)
Performance score of at least 60% by Karnofsky or performance status (PS) less than 3 (Eastern Cooperative Oncology Group [ECOG]) (age greater than or equal to 12 years), or Lansky play-performance scale of at least 60% or greater (age < 12 years)
Patients should have a life expectancy of at least 12 months and a Karnofsky or Lansky performance score of >= 50; patients who are wheelchair bound because of paralysis should be considered “ambulatory” when they are up in their wheel chair
Performance status: Karnofsky score < 60 for adult patients
Karnofsky score < 50%\r\n* Pediatric criteria\r\n** Lansky play-performance score < 40
Karnofsky score less than 60; pediatric criteria: Lansky Play-Performance Score < 40
Lansky >= 50 for patients =< 16 years old; Karnofsky >= 50 for patients > 16 years old
Patients must have a Lansky (< 16 years) or Karnofsky (> 16 years) score of at least 50
Karnofsky or Lansky performance score is >= 60%; the Lansky performance score should be used for participants < 16 years and the Karnofsky performance score for participants >= 16 years
Quality of life must be 3 by Lansky and 50% by Karnofsky
Karnofsky Performance Score ?50%
The presence of TAM high risk features at baseline (or screening if baseline visit is skipped): Patients ? 16 years must have a Lansky score of ? 70 and patients > 16 must have Karnofsky score ? 70% and/or proteinuria (> 30 mg/dL) measured in two urine spot analyses.
Karnofsky performance score 60
Karnofsky Performance Score < 60.
Subjects ? 16 years: Karnofsky score ? 70%.
Subjects < 16 years: Lansky score ? 70%.
Karnofsky/Lansky performance scale\r\n* ARM A: > 60%\r\n* ARM B: No limitation
Karnofsky Performance Score of at least 70.
Patients must have an ECOG score =< 3
Karnofsky performance scale (KPS for > 16 years of age) or Lansky performance score (LPS for =< 16 years of age) assessed within two weeks of registration must be >= 60
Karnofsky performance score < 60
Performance status: Eastern Cooperative Oncology Group (ECOG) 0, 1 or 2, or for children =< 10 years of age, Lansky >= 60; note: patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Performance score of at least 80% by Karnofsky
Have a Karnofsky Performance Score (KPS) equal to or greater than 70
Karnofsky performance score 70 or above
Performance status: Karnofsky (for participants >/= 16 years of age) or Lansky (for participants < 16 years of age) score of >/= 60
Adequate Karnofsky/Lansky Performance score
RECURRENT/ PROGRESSIVE DIPG (STRATUM 1): Karnofsky performance scale (KPS for > 16 years of age) or Lansky performance score (LPS for =< 16 years of age) assessed within 7 days of enrollment must be >= 50%; patients who are unable to walk because of neurologic deficits, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
NON-PROGRESSED DIPG (STRATUM 2): Karnofsky performance scale (KPS for > 16 years of age) or Lansky performance score (LPS for =< 16 years of age) assessed within 7 days of enrollment must be >= 50%; patients who are unable to walk because of neurologic deficits, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Karnofsky performance status > 80% for ages 16 years and older or Lansky play score > 50 for < 16 years
Patient has a minimum Karnofsky/Lansky Performance Level of at least 30 at the time of study entry.
ECOG Performance Score of 0 -2
Karnofsky Performance Score (KPS) ? 70%.
Performance status: Lansky >= 50 for patients who are =< 16 years old and Karnofsky >= 50% for patients who are > 16 years old
Karnofsky or Lansky performance score of greater than or equal to 50
Karnofsky or Lansky performance score is >= 60%; the Lansky performance score should be used for participants < 16 years and the Karnofsky performance score for participants >= 16 years
Karnofsky Performance Status (KPS) or Lansky Score ? 50
Karnofsky >= 50% for patients > 16 years of age and Lansky >= 50 for patients =< 16 years of age; note: neurologic deficits in patients with central nervous system (CNS) tumors must have been relatively stable for a minimum of 1 week prior to study enrollment; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Patient must have an ECOG Performance Score of 0, 1, or 2 (refer to Appendix II).
Performance score of at least 80% by Karnofsky or performance status (PS) < 3 (Eastern Cooperative Oncology Group [ECOG]) (age >= 12 years), or Lansky Play-Performance scale of at least 60% or greater (age < 12 years)
Karnofsky performance score of ? 60 (Eastern Cooperative Oncology Group [ECOG] performance score of 0, 1, or 2)
Pain scale score >= 5
Karnofsky performance score at least 70%
Mirels Criteria Score ? 8. (specific to the target humeral lesion and subject to minimum VAS score requirements)
Karnofsky or Lansky performance score is >= 60%; the Lansky performance score should be used for participants < 16 years and the Karnofsky performance score for participants >= 16 years
Karnofsky or Lansky (age-dependent) performance score >= 50
Karnofsky or Lansky performance score >= 50
Performance Level: Karnofsky > 50% for pts > 12 years; Lansky > 50% for pts < 12 years of age.
Patients must have an ECOG performance score of 0, 1, or 2.
Karnofsky performance score ?70.
ECOG Performance Score of 0 or 1
ECOG score greater than 1 (Karnofsky < 70%)
Karnofsky performance status score ? 50 for patients >16 years of age
Lansky performance status score ? 50 for patients ? 16 years of age
Karnofsky performance score ?60
Performance score of >=50% according to the Karnofsky/Lansky performance status scale.
Performance score of >=50% according to the Karnofsky/Lansky performance status scale (subjects with a performance status of <=50% can be enrolled if the subject's confinement to bed and inability to carry out activities is due solely to cancer-related pain, as assessed by the investigator).
Karnofsky Performance Score (KPS) ? 70%
Karnofsky or Lansky (age-dependent) performance score >= 50
Karnofsky >= 50% for patients > 16 years of age or Lansky >= 50% for patients =< 16 years of age; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Performance score ? 60 from Lansky Play Performance Scale if ?16 years
Karnofsky/Lansky score above 50%
All patients must have a projected survival time of at least 12 weeks and a Karnofsky performance score: >60% (or Zubrod score of >2).
Subject has screening MOD score of ?9
Performance Status: Karnofsky >= 50% for > 10 years of age; Lansky >= 50% for children =< 10 years of age; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purposes of assessing performance score
ECOG performance score of 0-2.
Karnofsky performance status less than 60% or Lansky less than 40% for patients younger than 16 years old
Patients must have a Lansky or Karnofsky performance scale score of >= 50% and patients must have a life expectancy of >= 2 months
Performance score (PS) < 2
Karnofsky >= 50% for patients > 16 years of age and Lansky >= 50 for patients =< 16 years of age; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Karnofsky Performance Status >= 50% for patients 16 years and older and Lansky Play Score >= 50 for patients under 16 years of age
Score of < 9 on the PHQ-4
Patient has Karnofsky score > 50 (ambulatory & capable of self-care)
KPS Score < 60 (See \Definitions\ below)
Have a baseline Distress Thermometer score of >= 4, or an Impact of Events Scale score of >= 9, or Center for Epidemiological Studies Depression Scale score of >= 16 (i.e. clinically meaningful thresholds)
Gleason score of 6 - 10
Performance status: Lansky >= 50 for patients who are =< 16 years old and Karnofsky >= 50% for patients who are > 16 years old
Karnofsky score >= 60%
Karnofsky performance score >= 50%
Either a score of > 15 on the Brief Penn State Worry Questionnaire OR a score >= 12 on the Brooding Subscale of the Rumination Response Scale
Karnofsky performance scale (KPS) score < 80
Performance score minimum requirement is >= 50 on Karnofsky/Lanksy performance scale
Have a Karnofsky score >= 70
Lansky or Karnofsky performance >= 40%
Karnofsky performance score or Lansky Play-Performance Scale score < 80
Has a KPS score of >= 50
Karnofsky performance scale (KPS) score of >= 60
Performance status must be > 60 from Lansky (age 1 to 16) or Karnofsky (age > 16)
Lansky/Karnofsky score < 60
Subject has a Karnofsky score <50, or a World Health Organization (WHO)/ Eastern Cooperative Oncology Group (ECOG) performance status ?3. Subjects who have a performance status of 3 may be considered for the study if the removal of their fluid would likely improve their performance score by 1 or more.
Karnofsky performance score (KPS) >= 70%
Karnofsky score >= 70% at the time of screening
AYA is able to participate in sessions as evaluated by the Karnofsky/Lansky score of 50% or greater
Patient has Karnofsky score >= 50 or World Health Organization (WHO)/Eastern Cooperative Oncology Group (ECOG) =< 2 if >= 16 years of age
Lansky score >= 50 for patients age < 16
ECOG score of 0,1,or 2 OR Karnofsky score of 50 or higher
Karnofsky/Lansky score of >= 50
ELIGIBILITY CRITERIA FOR ENROLLMENT ONTO APEC1621SC: Karnofsky >= 50% for patients > 16 years of age and Lansky >= 50 for patients =< 16 years of age); Note: neurologic deficits in patients with CNS tumors must have been stable for at least 7 days prior to study enrollment; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
GENERAL INCLUSION CRITERIA FOR SUBPROTOCOLS: Karnofsky >= 50% for patients > 16 years of age and Lansky >= 50 for patients =< 16 years of age); Note: neurologic deficits in patients with CNS tumors must have been stable for at least 7 days prior to study enrollment; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Karnofsky or Lansky Performance Score < 70%
Adequate performance status, defined as Karnofsky score greater than 70%;
Patients must have a Lansky or Karnofsky Performance Scale score of > 50% and patients must have a life expectancy of ? 2 months.
Karnofsky Performance Status score ? 70% or Eastern Cooperative Oncology Group Performance Status score of 0 to 2.
Karnofsky score >= 70%
Karnofsky score >= 70%
Performance status by Karnofsky of >= 70% or Lansky > 70% for patients < 16 years of age
Karnofsky or Lansky score of > 60%
Karnofsky score < 60 for adult patients
Lansky-play performance score < 50 for pediatric patients
Patients must have a performance status corresponding to Eastern Cooperative Oncology Group (ECOG) scores of 0 or 1 (>= 70% for Karnofsky/Lansky); use Karnofsky for patients > 16 years of age and Lansky for patients =< 16 years of age
Karnofsky score >= 70%
Score at least a 5 on the Contemplation Ladder
Lansky score < 60%
Lansky score < 60%
Performance status: Karnofsky/Lansky score > 60%.
Karnofsky performance score over 60
Patients with a Karnofsky/Lansky score of >= 50
Karnofsky Performance Score of ?60.
Lansky score ? 50 or
Karnofsky score > 50 or
Patients must have a Karnofsky performance score of 70% or above
Karnofsky performance score < 70%
Has a Lansky Play Performance score ?60 (participants ?16 years of age) or a Karnofsky score ?60 (participants >16 years of age)
Karnofsky Performance Score < 70%
ECOG Performance Score of 0 or 1 within 14 days prior to registration
Karnofsky performance score >= 70 within 45 days prior to entry
Karnofsky performance score of at least 80
Karnofsky score of 60 or higher
Gleason score of >= 8 (4+4)
Karnofsky performance of >= 50 corresponding to Eastern Cooperative Oncology Group (ECOG) categories 0, 1, or 2; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Karnofsky performance score >= 60
Group I: Karnofsky performance score (KPS) >= 80
Group II: Karnofsky performance score (KPS) >= 80
Group III: Karnofsky performance score (KPS) >= 80
Karnofsky score of >= 60
Karnofsky performance score >= 70
Patient must have a Lansky or Karnofsky performance of > 40% corresponding to Eastern Cooperative Oncology Group (ECOG) categories 0, 1, or 2; Karnofsky will be used for patients > 16 years of age and Lansky for patients < 16 years of age; patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered ambulatory for the purpose of assessing the performance score
Karnofsky (patients ? 16 years)/Lansky (patients < 16 years) index ? 70.
Gleason score =< 6
Karnofsky performance score >= 70
Have an ECOG score of 0-1